MELPHA (Emcure Pharmaceuticals Pty Ltd)
Product name
MELPHA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
166 working days (255)
Active ingredients
melphalan (as hydrochloride)
Registration type
New generic medicine
Indication
MELPHA (injection) is indicated for the treatment of patients with multiple myeloma for whom oral therapy is not appropriate.